Developments BioLight, Alexion to explore natural tears for diagnosis of retinal diseases BioLight (TASE:BOLT) signed a research collaboration agreement with Alexion, a rare disease unit of AstraZeneca, to explore a potentially ground-breaking technology that utilizes natural tears for the potential... May 30, 2023